Results for hypogonadotropic translation from English to Slovenian

men with hypogonadotropic hypogonadism
moški s hipogonadotropnim hipogonadizmom

in clinical trials the efficacy of the combination of follitropin alfa and lutropin alfa has been demonstrated in women with hypogonadotropic hypogonadism.
v kliničnih preskušanjih z ženskami s hipogonadotropnim hipogonadizmom so potrdili učinkovitost kombinacije folitropina alfa in lutropina alfa.

ovaleap is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotropic hypogonadism with concomitant human chorionic gonadotropin (hcg) therapy.
zdravilo ovaleap je s sočasnim zdravljenjem s humanim horionskim gonadotropinom (hcg) indicirano za stimulacijo spermatogeneze pri moških, ki imajo prirojen ali pridobljen hipogonadotropni hipogonadizem.

in lh and fsh deficient women (hypogonadotropic hypogonadism), the objective of follitropin alfa therapy in association with lutropin alfa is to develop a single mature graafian follicle from which the oocyte will be liberated after the administration of hcg.
pri ženskah s pomanjkanjem lh in fsh (hipogonadotropni hipogonadizem), je cilj zdravljenja s folitropinom alfa skupaj z lutropinom alfa razvoj enega samega zrelega graafovega folikla, iz katerega se bo sprostilo jajčece po dajanju hcg.